15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Balchem Corporation, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $162.00 to $215.00, so the covering firms are broadly aligned. The average target of $188.50 sits 10% above the current $170.67. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.47 next quarter toward $6.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Balchem Corporation.
As of Sep, 1 of 2 firms rate BCPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BCPC EPS & revenue forecast
EPS · NEXT QUARTER
$1.47
Range $1.46 – $1.47 · 2 analysts · +12% YoY
Next period, 2 analysts expect Balchem Corporation to earn $1.47 a share (range $1.46 – $1.47), versus $1.31 a year earlier. Full-year consensus is $5.84, growing to $6.27 the year after.
REVENUE · NEXT QUARTER
$287.8M
Range $280.6M – $298.3M · 2 analysts · +9% YoY
Revenue is expected to reach $287.8M (range $280.6M – $298.3M), +9.2% year-over-year. Full-year consensus is $1.1B, rising to $1.2B next year.
Top analysts covering Balchem Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BCPC.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #312
Buy
$215.00+26.0% to target
Overall win rate
36%
+ Follow
#2
DH
Daniel Harriman
Sidoti
Buy
$234.00+37.1% to target
Coverage
—
+ Follow
#3
AC
Artem Chubarov
Redburn Atlantic
Hold
$162.00-5.1% to target
Coverage
—
+ Follow
#4
AC
Artem Chubarov
Rothschild & Co
Hold
$162.00-5.1% to target
Coverage
—
+ Follow
BCPC stock forecast FAQ
What is BCPC's average 12-month price target?+
The 2 analysts with a live target average $188.50 for Balchem Corporation over the next 12 months, ranging from a $215.00 high to a $162.00 low.
Is BCPC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BCPC?+
The Street-high target is $215.00 (HC Wainwright & Co.), and the Street-low is $162.00 (Rothschild & Co). The average of all 2 active targets is $188.50.
How many Wall Street analysts cover BCPC?+
2 analysts have an active rating on Balchem Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BCPC?+
Among analysts who currently cover BCPC, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #312). Their current call is Buy with a $215.00 target.
What is Balchem Corporation's projected EPS for next quarter?+
The consensus estimate is $1.47 per share (range $1.46 – $1.47) across 2 analysts. Full-year EPS is projected at $5.84, rising to $6.27 the following year.
How much revenue is Balchem Corporation expected to report next quarter?+
Consensus revenue is $287.8M (range $280.6M – $298.3M). Full-year revenue is projected at $1.1B, growing to $1.2B next year.
Have analysts been upgrading or downgrading BCPC lately?+
As of Sep, 1 of 2 firms rate BCPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BCPC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
